BioLight Life Sciences Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was ILS 31,000. Operating loss was ILS 11.328 million compared to ILS 10.524 million a year ago. Net loss was ILS 13.382 million compared to ILS 12.591 million a year ago. Basic loss per share was ILS 2.95 compared to ILS 2.77 a year ago. Basic loss per share from continuing operations was ILS 2.9 compared to ILS 2.92 a year ago.